“Theravance Biopharma (TBPH)… Overall, there are 5 reviews on file, and all are to Buy, making the Strong Buy consensus unanimous. TBPH shares are priced at $16.95, and their $33.60 average price target suggests a 97% upside from that level…  NiSource,… Continue Reading…